Abstract:The emerging contaminant nanoplastics (NPs) have received considerable attention. Due to their tiny size and unique colloidal properties, NPs could more easily enter the body and cross biological barriers with inhalation exposure. While NPs-induced hepatotoxicity has been reported, the hepatic impact of inhaled NPs was still unknown. To close this gap, a 40 nm polystyrene NPs (PS-NPs) inhalation exposure mice model was developed to explore the hepatotoxicity during acute (1 week), subacute (4 weeks), and subchronic period (12 weeks), with four exposure doses (0, 16, 40, and 100 μg/day). Results showed that inhaled PS-NPs caused a remarkable increase of ALT , AST , and ALP with a decrease of CHE , indicating liver dysfunction. Various histological abnormalities and significantly higher levels of inflammation in a dose- and time-dependent manner were observed. Moreover, after 4 weeks and 12 weeks of exposure, Masson staining and upregulated expression of TGF-β, α-SMA, and Col1a1 identified that inhaled PS-NPs exposure triggered the progression of liver fibrosis with the exposure time prolonged. From the mechanistic perspective, transcriptome analysis revealed that ferroptosis was involved in PS-NPs-induced liver hepatotoxicity, and key features of ferroptosis were detected, including persistent oxidative stress, iron overload, increased LPO, mitochondria damage, and the expression changes of GPX4, TFRC, and Ferritin. And in vitro and in vivo recovery tests showed that ferroptosis inhibitor Fer-1 treatment alleviated liver injury and fibrosis. The above results confirmed the critical role of ferroptosis in PS-NPs-induced hepatotoxicity. Furthermore, to better conclude our findings and understand the mechanistic causality within it, an adverse outcome pathway (AOP) framework was established. In total, this present study conducted the first experimental assessment of inhalation exposure to PS-NPs on the liver, identified that continuous inhaled PS-NPs could cause liver injury and fibrosis, and PS-NPs- ferroptosis provided a novel mechanistic explanation.

Long-term Pulmonary Iron Oxide Nanoparticles Exposure Disrupts Hepatic Iron-Lipid Homeostasis and Increases Plaque Vulnerability in ApoE-/- Mice

Effects Of Long-Term Exposure To Zinc Oxide Nanoparticles On Development, Zinc Metabolism And Biodistribution Of Minerals (Zn, Fe, Cu, Mn) In Mice

Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.

Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis

Changes of Serum Parameters of Tio2 Nanoparticle-Induced Atherosclerosis in Mice

The promotion effect of novel magnetic nanoparticles on atherosclerotic plaque vulnerability in apolipoprotein E-/- mice.

Cardiovascular Effects of Pulmonary Exposure to Titanium Dioxide Nanoparticles in ApoE Knockout Mice.

Long-term polystyrene nanoplastic exposure disrupt hepatic lipid metabolism and cause atherosclerosis in ApoE -/- mice

Ferroptosis participated in inhaled polystyrene nanoplastics-induced liver injury and fibrosis

Iron Oxide Nanoparticles Aggravate Hepatic Steatosis and Liver Injury in Nonalcoholic Fatty Liver Disease Through BMP-SMAD-mediated Hepatic Iron Overload

Long-term Exposure of Molybdenum Disulfide Nanosheets Leads to Hepatic Lipid Accumulation and Atherogenesis in Apolipoprotein E Deficient Mice.

Comparative Study of Pulmonary Responses to Nano- and Submicron-Sized Ferric Oxide in Rats.

Nickel Nanoparticles Induced Hepatotoxicity in Mice via Lipid-Metabolism-Dysfunction-Regulated Inflammatory Injury.

Susceptibility of Overweight Mice to Liver Injury As a Result of the ZnO Nanoparticle-Enhanced Liver Deposition of Pb2.

Iron Oxide Nanoparticles Cause Surface Coating- and Core Chemistry-Dependent Endothelial Cell Ferroptosis.

Pulmonary Toxicity Study Of Iron Oxide Nanoparticles In Rats After Multiple Pulmonary Perfusion

Oxidative Stress and Apoptosis Induced by Iron Oxide Nanoparticles in Cultured Human Umbilical Endothelial Cells

Long-term administration of low-dose selenium nanoparticles with different sizes aggravated atherosclerotic lesions and exhibited toxicity in apolipoprotein E-deficient mice

Macrophage Iron Accumulation Promotes the Development of Atherosclerosis in Apolipoprotein E Knockout Mice

Intracellular Exposure Dose-Associated Susceptibility of Steatotic Hepatocytes to Metallic Nanoparticles

Iron-bearing Nanoparticles Trigger Human Umbilical Vein Endothelial Cells Ferroptotic Responses by Promoting Intracellular Iron Level